// App-Quantinova.ai

: Predicting disease progression in men with localized high risk prostate cancer undergoing radical prostatectomy.

Researchers

Presenter

  • Yaw A. Nyame

Principal Investigators

  • Jeffrey J. Tosoian

  • Ridwan Alam

  • Lamont Wilkins

  • Kasra Yousefi

  • Meera Chappidi

  • Chandana A. Reddy

  • Elizabeth B. Humphreys

  • Debasish Sundi

  • Brian F. Chapin

  • Andrew J. Stephenson

  • Eric A. Klein

  • Ashley Ross

Medical Centers

  • Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, USA

  • James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved